logo
Plus   Neg
Share
Email

Constellation Brands Sees FY Beer Sales Growth To Be 7%-8%

Constellation Brands Inc. (STZ) said that it expects beer sales growth for fiscal year 2021 to be 7%-8% including the impact of the Ballast Point divestiture and annual organic net sales growth of 8%-10%.

In Wine and Spirits segment, the company expects net sales and operating income for fiscal year 2021 to be down about 30% to 35%, respectively; It retained Power Brand portfolio.

Fiscal 2021 earnings per share guidance is unavailable at this time due to potential impacts on the business from COVID-19. However, the company sets forth management's pre-COVID-19 business expectations for fiscal 2021 compared to fiscal 2020 actual results.

The company declared a quarterly cash dividend of $0.75 per share of Class A Common Stock and $0.68 per share of Class B Common Stock, payable on May 19, 2020, to stockholders of record as of the close of business on May 5, 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
Follow RTT